sentence1
stringlengths
1.08k
96.5k
sentence2
stringlengths
51
966
labels
stringclasses
3 values
metadata
stringlengths
123
2.56k
TITLE: Comparative evaluation of retention of prefabricated and conventional cast post: An ABSTRACT.BACKGROUND AND OBJECTIVES:: This study was conducted to evaluate the retention of various prefabricated posts and to compare them with that of the conventional cast post. ABSTRACT.MATERIALS AND METHODS:: A sam...
Intervention: stainless steel posts Comparator: Cast metal post - control group Outcome: mean load
-1
{"evidence_spans": [{"end": 6877, "start": 6753, "text": "< 0.001) was observed. The difference in mean load between cast metal and stainless steel was also found to be statistically"}], "id": "10542", "pmcid": "4170550", "prompt_id": "10542", "split_group_id": "4170550", "votes": {"-1": 1}}
TITLE: Comparative evaluation of retention of prefabricated and conventional cast post: An ABSTRACT.BACKGROUND AND OBJECTIVES:: This study was conducted to evaluate the retention of various prefabricated posts and to compare them with that of the conventional cast post. ABSTRACT.MATERIALS AND METHODS:: A sam...
Intervention: prefabricated stainless steel post Comparator: carbon fiber posts, glass fiber posts Outcome: Among the prefabricated posts highest bond strength
1
{"evidence_spans": [{"end": 1340, "start": 1236, "text": "SULTS::\r\nThe bond strength of all the prefabricated posts was significantly lower than the conventional "}, {"end": 1593, "start": 1342, "text": "st post. Among the prefabricated posts highest bond strength was obtained for prefabricated stainless steel post a...
TITLE: Ultrasound Guided Needle Aspiration versus Surgical Drainage in the management of breast abscesses: a Ugandan experience ABSTRACT.BACKGROUND: Despite breast abscess becoming less common in developed countries, it has remained one of the leading causes of morbidity in women in developing countries. A random...
Intervention: ultrasound guided needle aspiration Comparator: Incision and drainage Outcome: abscess size - females with breast abscess
0
{"evidence_spans": [{"end": 1007, "start": 923, "text": "9 cm. The two groups were comparably in demographic characteristic and breast absces"}], "id": "10547", "pmcid": "3284878", "prompt_id": "10547", "split_group_id": "3284878", "votes": {"0": 2}}
TITLE: Ultrasound Guided Needle Aspiration versus Surgical Drainage in the management of breast abscesses: a Ugandan experience ABSTRACT.BACKGROUND: Despite breast abscess becoming less common in developed countries, it has remained one of the leading causes of morbidity in women in developing countries. A random...
Intervention: ultrasound guided needle aspiration Comparator: Incision and drainage Outcome: Hazard rate - females with breast abscess
0
{"evidence_spans": [{"end": 16415, "start": 16277, "text": "(Log rank: 0.24, df 1 P 0.63) (Figure 4). The Hazard rate of patients in Arm A was 0.93 times less the hazard rate of group B and this was"}, {"end": 16427, "start": 16277, "text": "(Log rank: 0.24, df 1 P 0.63) (Figure 4). The Hazard rate of patients in Arm A...
TITLE: Effect of Village Health Team Home Visits and Mobile Phone Consultations on Maternal and Newborn Care Practices in Masindi and Kiryandongo, Uganda: A Community-Intervention Trial ABSTRACT.INTRODUCTION: The World Health Organisation recommends home visits conducted by Community Health Workers (in Uganda kno...
Intervention: intervention package for maternal care and essential newborn care practices Comparator: usual maternal and newborn educational messages Outcome: timely care-seeking for newborn illness
1
{"evidence_spans": [{"end": 35228, "start": 35039, "text": " showed significant associations with the intervention. After further analysis, cord care [3.05(1.81\u20135.12); p<0.001], thermal care [7.58(2.52\u201322.82); p<0.001], and timely care-seeking for n"}], "id": "10550", "pmcid": "4839625", "prompt_id": "10550",...
TITLE: The Effect of Low-Level Laser Therapy on Hearing ABSTRACT: One purported use of low-level laser therapy (LLLT) is to promote healing in damaged cells. The effects of LLLT on hearing loss and tinnitus have received some study, but results have been equivocal. The purpose of this study was to determine if LL...
Intervention: treatment - low-level laser therapy (LLLT) Comparator: placebo Outcome: high-frequency average (HFA)
0
{"evidence_spans": [{"end": 18174, "start": 18020, "text": "ection 3, the fourth assumption was likely violated. An analysis of variance showed no difference between group means for changes in PTA (F(2,57) = 0.0"}, {"end": 18171, "start": 18051, "text": " was likely violated. An analysis of variance showed no dif...
TITLE: Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated with improvement in cognitive function ABSTRACT.BACKGROUND: Persistent neuroinflammation and disruptions in brain energy metabolism is commonly seen in traum...
Intervention: Mild TBI Comparator: Control Outcome: pAMPK/AMPK ratio in the hippocampus
-1
{"evidence_spans": [{"end": 22540, "start": 22293, "text": "tio compared to the sham control animals. Examination of pAMPK/AMPK ratio in the hippocampus also showed significant main effects of mTBI (F(3,30) = 11.33, p < 0.05) and housing condition (F(3,30) = 12.11, p < 0.05) with the pattern of changes sim"}], "id": "1...
TITLE: Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer ABSTRACT.BACKGROUND AND OBJECTIVES: This trial evaluated the safety and efficacy of the Genoss drug-eluting coronary stent. ABSTRACT.METHODS: This study was a prospective, m...
Intervention: Genoss drug-eluting stent (DES) Comparator: Promus Element Outcome: In-stent late lumen loss at 9 months
0
{"evidence_spans": [{"end": 1269, "start": 1142, "text": "M group. In-stent late lumen loss at 9 months was not significantly different between the 2 groups (0.11\u00b10.25 vs. 0.16\u00b10.43 mm,"}], "id": "10572", "pmcid": "5711682", "prompt_id": "10572", "split_group_id": "5711682", "votes": {"0": 1}}
TITLE: Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer ABSTRACT.BACKGROUND AND OBJECTIVES: This trial evaluated the safety and efficacy of the Genoss drug-eluting coronary stent. ABSTRACT.METHODS: This study was a prospective, m...
Intervention: Genoss drug-eluting stent (DES) Comparator: Promus Element Outcome: no myocardial infarction (MI)
0
{"evidence_spans": [{"end": 1323, "start": 1271, "text": "=0.567). There was no MI or stent thrombosis in eith"}, {"end": 12462, "start": 12371, "text": "ere not significantly different (Table 4). For clinical outcomes, there were no MI or stent"}], "id": "10573", "pmcid": "5711682", "prompt_id": "10573", "split_group_...
TITLE: Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia ABSTRACT.BACKGROUND: Plant sterols are an established non-pharmacological means to reduce total and LDL blood cholesterol concentrations and are therefore recommended for cholest...
Intervention: soy drink enriched with 2.6 g plant sterol esters Comparator: soy drink not enriched with 2.6 g plant sterol esters Outcome: triglycerides
0
{"evidence_spans": [{"end": 1947, "start": 1786, "text": "ctively. Mean reductions in total, LDL and non-HDL cholesterol were significantly greater than in the placebo group (p < 0.05). HDL-C and triglycerides were not "}, {"end": 1946, "start": 1905, "text": "< 0.05). HDL-C and triglycerides were not"}], "id": "10576"...
TITLE: Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus ABSTRACT.OBJECTIVE: To assess the efficacy and safety of anifrolumab, a type I interferon (IFN) receptor antagonist, in a phase IIb, randomized, double‐blind, placebo‐controlled study of adult...
Intervention: Anifrolumab 300 mg Comparator: Placebo Outcome: Percentage of patients achieving an SLE Responder Index 4
1
{"evidence_spans": [{"end": 1829, "start": 1609, "text": "ESULTS:\r\nThe primary end point was met by more patients treated with anifrolumab (34.3% of 99 for 300 mg and 28.8% of 104 for 1,000 mg) than placebo (17.6% of 102) (P = 0.014 for 300 mg and P = 0.063 for 1,000 mg, versus"}, {"end": 2658, "start": 2061, "text":...
TITLE: Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia ABSTRACT.BACKGROUND: Plant sterols are an established non-pharmacological means to reduce total and LDL blood cholesterol concentrations and are therefore recommended for cholest...
Intervention: soy drink enriched with 2.6 g plant sterol esters Comparator: soy drink not enriched with 2.6 g plant sterol esters Outcome: non-HDL-cholesterol
-1
{"evidence_spans": [{"end": 1904, "start": 1786, "text": "ctively. Mean reductions in total, LDL and non-HDL cholesterol were significantly greater than in the placebo group (p"}, {"end": 6671, "start": 6590, "text": "tively. In addition, non-HDL-cholesterol was reduced by 0.35 mmol/l (p < 0.01) an"}], "id": "10579", "...
TITLE: Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus ABSTRACT.OBJECTIVE: To assess the efficacy and safety of anifrolumab, a type I interferon (IFN) receptor antagonist, in a phase IIb, randomized, double‐blind, placebo‐controlled study of adult...
Intervention: Anifrolumab 1000 mg Comparator: Placebo Outcome: Percentage of patients achieving an SLE Responder Index 6
1
{"evidence_spans": [{"end": 2658, "start": 2061, "text": "ctively. At week 52, patients treated with anifrolumab achieved greater responses in SRI(4) (40.2% versus 62.6% [P < 0.001] and 53.8% [P = 0.043] with placebo, anifrolumab 300 mg, and anifrolumab 1,000 mg, respectively), BICLA (25.7% versus 53.5% [P < 0.001] and...
TITLE: Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus ABSTRACT.OBJECTIVE: To assess the efficacy and safety of anifrolumab, a type I interferon (IFN) receptor antagonist, in a phase IIb, randomized, double‐blind, placebo‐controlled study of adult...
Intervention: Anifrolumab 1000 mg Comparator: Placebo Outcome: Adverse events
0
{"evidence_spans": [{"end": 3054, "start": 2946, "text": " groups. Incidence of serious adverse events was similar between groups (18.8% versus 16.2% and 17.1%, respe"}, {"end": 35671, "start": 35319, "text": "d in the 1,000\u2010mg anifrolumab group for the safety analyses. The percentages of patients with at least 1 ...
TITLE: Effects of parecoxib on postoperative pain and opioid-related symptoms following gynecologic surgery ABSTRACT.OBJECTIVE: To examine the analgesic and opioid-sparing effects of parecoxib following major gynecologic surgery. ABSTRACT.METHODS: This is a large subset analysis of patients from a multicenter...
Intervention: Parecoxib/valdecoxib Comparator: Placebo Outcome: Pain after 2 days
-1
{"evidence_spans": [{"end": 826, "start": 693, "text": "ESULTS:\r\nPain scores were reduced in the PAR/VAL group (n=98), relative to placebo (n=97), on Day 2 (\u221221%, P<0.001) and Day 3 (\u221223%, "}], "id": "10073", "pmcid": "5135478", "prompt_id": "10073", "split_group_id": "5135478", "votes": {"-1": 2}}
TITLE: Effects of parecoxib on postoperative pain and opioid-related symptoms following gynecologic surgery ABSTRACT.OBJECTIVE: To examine the analgesic and opioid-sparing effects of parecoxib following major gynecologic surgery. ABSTRACT.METHODS: This is a large subset analysis of patients from a multicenter...
Intervention: Parecoxib/valdecoxib Comparator: Placebo Outcome: Pain after 3 days
-1
{"evidence_spans": [{"end": 826, "start": 693, "text": "ESULTS:\r\nPain scores were reduced in the PAR/VAL group (n=98), relative to placebo (n=97), on Day 2 (\u221221%, P<0.001) and Day 3 (\u221223%, "}], "id": "10074", "pmcid": "5135478", "prompt_id": "10074", "split_group_id": "5135478", "votes": {"-1": 2}}
TITLE: Effects of parecoxib on postoperative pain and opioid-related symptoms following gynecologic surgery ABSTRACT.OBJECTIVE: To examine the analgesic and opioid-sparing effects of parecoxib following major gynecologic surgery. ABSTRACT.METHODS: This is a large subset analysis of patients from a multicenter...
Intervention: Parecoxib/valdecoxib Comparator: Placebo Outcome: Pain interference with function after 2 days
-1
{"evidence_spans": [{"end": 992, "start": 827, "text": "=0.004). Pain interference with function scores were also significantly lower in the PAR/VAL group, compared with placebo, on Day 2 (\u221229%, P<0.001) and Day 3 (\u221228%, "}], "id": "10075", "pmcid": "5135478", "prompt_id": "10075", "split_group_id": "5135478"...
TITLE: Effects of parecoxib on postoperative pain and opioid-related symptoms following gynecologic surgery ABSTRACT.OBJECTIVE: To examine the analgesic and opioid-sparing effects of parecoxib following major gynecologic surgery. ABSTRACT.METHODS: This is a large subset analysis of patients from a multicenter...
Intervention: Parecoxib/valdecoxib Comparator: Placebo Outcome: Risk of experiencing ≥2 opioid-related symptoms
-1
{"evidence_spans": [{"end": 10289, "start": 10143, "text": "llowing surgery (Table 2). The overall RR of experiencing \u22652 opioid-related symptoms on Day 2 was significantly lower with PAR/VAL compared with p"}, {"end": 10289, "start": 10144, "text": "lowing surgery (Table 2). The overall RR of experiencing \u22652 ...
TITLE: Effect of oral nitrate supplementation on pulmonary hemodynamics during exercise and time trial performance in normoxia and hypoxia: a randomized controlled trial ABSTRACT: Background: Hypoxia-induced pulmonary vasoconstriction increases pulmonary arterial pressure (PAP) and may impede right heart function...
Intervention: Sodium nitrate supplementation in hypoxia Comparator: Control Outcome: Time to completing trial cycling
0
{"evidence_spans": [{"end": 1651, "start": 1494, "text": "). Hypoxia impaired time-to-completion during TT (p < 0.05), while no improvements were observed with nitrate supplementation in normoxia or hypoxia (p > 0.0"}], "id": "10081", "pmcid": "4604314", "prompt_id": "10081", "split_group_id": "4604314", "votes": {"0":...
TITLE: Effect of oral nitrate supplementation on pulmonary hemodynamics during exercise and time trial performance in normoxia and hypoxia: a randomized controlled trial ABSTRACT: Background: Hypoxia-induced pulmonary vasoconstriction increases pulmonary arterial pressure (PAP) and may impede right heart function...
Intervention: Sodium nitrate supplementation in normoxia Comparator: Control Outcome: Right ventricle to right atrium pressure gradient
0
{"evidence_spans": [{"end": 1315, "start": 1166, "text": "s: During steady state exercise, hypoxia elevated RV-RA gradient (p > 0.05), while oral nitrate supplementation did not alter RV-RA gradient (p > 0.0"}], "id": "10084", "pmcid": "4604314", "prompt_id": "10084", "split_group_id": "4604314", "votes": {"0": 2}}
TITLE: Evaluation of preventive effects of colostrum against neonatal conjunctivitis: A randomized clinical trial ABSTRACT.BACKGROUND:: Neonatal conjunctivitis leads to several ocular consequences in the affected neonates such as blindness. Currently available therapeutic options include NaNO3, Gentamicin, Neomyc...
Intervention: group receiving topical colostrum Comparator: control group Outcome: beneficial preventive effects against neonatal conjunctivitis
1
{"evidence_spans": [{"end": 1183, "start": 1071, "text": "SULTS::\r\nOur data demonstrate the beneficial preventive effects of Colostrum against neonatal conjunctivitis (P "}, {"end": 1182, "start": 1075, "text": "S::\r\nOur data demonstrate the beneficial preventive effects of Colostrum against neonatal conjunctivitis...
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: Total duration of intubation - In infants by birth weight >1,500 g - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 14076, "start": 13855, "text": "M OUTCOME AND COMPLICATIONS:\r\nTotal duration of intubation was not significantly different between Newfactan\u00ae group and Surfacten\u00ae group (14.3\u00b118.6 days versus 12.2\u00b118.8 days) in <1,500 g group, as well as in \u22651,500 g gro"}], "id": "...
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: clinical efficacy (infants birth weight <1,500 g) - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 1615, "start": 1480, "text": "s. We concluded that Newfactan\u00ae was comparable to Surfacten\u00ae in the clinical efficacy in the treatment of RDS in both birth weight grou"}, {"end": 1614, "start": 1498, "text": "at Newfactan\u00ae was comparable to Surfacten\u00ae in the clinical effica...
TITLE: Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes ABSTRACT.INTRODUCTION: To investigate whether vildagliptin add-on insulin therapy improves glycemic variations in patients with uncontrolled type 2 diabetes (T2D) compared to patients with placeb...
Intervention: Vildagliptin Comparator: Placebo Outcome: Severe hypoglycemia
0
{"evidence_spans": [{"end": 1550, "start": 1487, "text": "0\u20130600). A severe hypoglycemic episode was not observed in eith"}], "id": "10089", "pmcid": "5630558", "prompt_id": "10089", "split_group_id": "5630558", "votes": {"0": 2}}
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: clinical efficacy (infants birth weight >1,500 g) - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 1615, "start": 1480, "text": "s. We concluded that Newfactan\u00ae was comparable to Surfacten\u00ae in the clinical efficacy in the treatment of RDS in both birth weight grou"}, {"end": 1614, "start": 1498, "text": "at Newfactan\u00ae was comparable to Surfacten\u00ae in the clinical effica...
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: response type to surfactant - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 12035, "start": 11919, "text": "three doses of surfactant. There was no significant difference in the response type to surfactant between Newfactan\u00ae"}], "id": "10602", "pmcid": "2782153", "prompt_id": "10602", "split_group_id": "2782153", "votes": {"0": 1}}
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: In ≥1,500 g group, the total doses of surfactant instilled - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 12870, "start": 12689, "text": "t instillation (Table 2). In \u22651,500 g group, the total doses of surfactant instilled were not significantly different between Newfactan\u00ae group and Surfacten\u00ae group (one dose 87 vs."}, {"end": 12871, "start": 12689, "text": "t instillation (Tabl...
TITLE: Comparison of Clinical Efficacy of Newfactan® versus Surfacten® for the Treatment of Respiratory Distress Syndrome in the Newborn Infants ABSTRACT: Newfactan® is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan...
Intervention: Newfactan Comparator: Surfacten Outcome: Total duration of intubation - In infants by birth weight <1,500 g - treatment of respiratory distress syndrome (RDS)
0
{"evidence_spans": [{"end": 14076, "start": 13855, "text": "M OUTCOME AND COMPLICATIONS:\r\nTotal duration of intubation was not significantly different between Newfactan\u00ae group and Surfacten\u00ae group (14.3\u00b118.6 days versus 12.2\u00b118.8 days) in <1,500 g group, as well as in \u22651,500 g gro"}], "id": "...
TITLE: Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes ABSTRACT.INTRODUCTION: To investigate whether vildagliptin add-on insulin therapy improves glycemic variations in patients with uncontrolled type 2 diabetes (T2D) compared to patients with placeb...
Intervention: Vildagliptin Comparator: Placebo Outcome: Glucose concentration
-1
{"evidence_spans": [{"end": 1286, "start": 1117, "text": "n group. CGM data showed that patients with vildagliptin add-on therapy had a significantly lower 24-h mean glucose concentration and mean amplitude of glycemic excursio"}], "id": "10087", "pmcid": "5630558", "prompt_id": "10087", "split_group_id": "5630558", "v...
TITLE: Effects of aquatic exercise and CES treatment on the changes of cognitive function, BDNF, IGF-1, and VEGF of persons with intellectual disabilities ABSTRACT.[PURPOSE]: The purpose of this study was to investigate the effects of aquatic exercise and CES treatment on the cognitive function by using K-WAB and...
Intervention: Exercise + cranial electrotherapy stimulation Comparator: Exercise Outcome: Cognitive function level
1
{"evidence_spans": [{"end": 963, "start": 836, "text": "follows: Cognitive function level increased significantly in the exercise+CES group compared to those in the exercise and contr"}], "id": "10098", "pmcid": "4241936", "prompt_id": "10098", "split_group_id": "4241936", "votes": {"1": 2}}
TITLE: Effects of aquatic exercise and CES treatment on the changes of cognitive function, BDNF, IGF-1, and VEGF of persons with intellectual disabilities ABSTRACT.[PURPOSE]: The purpose of this study was to investigate the effects of aquatic exercise and CES treatment on the cognitive function by using K-WAB and...
Intervention: Exercise + cranial electrotherapy stimulation Comparator: Control Outcome: Cognitive function level
1
{"evidence_spans": [{"end": 963, "start": 836, "text": "follows: Cognitive function level increased significantly in the exercise+CES group compared to those in the exercise and contr"}], "id": "10099", "pmcid": "4241936", "prompt_id": "10099", "split_group_id": "4241936", "votes": {"1": 2}}
TITLE: Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer ABSTRACT: The aim of this study was t...
Intervention: xeloda/ epirubicin/ cyclophosphamide (XEC) Comparator: 5-fluorouracil/ epirubicin/ cyclophosphamide (FEC) Outcome: 3/4 grade nausea/vomiting/diarrhea - in axillary lymph node (LN)-positive early-stage breast cancer
1
{"evidence_spans": [{"end": 1637, "start": 1490, "text": "y. Compared to FEC, XEC was associated with more hand-foot syndrome (57% vs 11%, P<0.001) and 3/4 grade nausea/vomiting/diarrhea (30% vs 14%, P=0.0"}, {"end": 1678, "start": 1490, "text": "y. Compared to FEC, XEC was associated with more hand-foot syndrome (57% ...
TITLE: Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer ABSTRACT: The aim of this study was t...
Intervention: xeloda/ epirubicin/ cyclophosphamide (XEC) Comparator: 5-fluorouracil/ epirubicin/ cyclophosphamide (FEC) Outcome: rate of pathological complete response in primary tumor - in axillary lymph node (LN)-positive early-stage breast cancer
1
{"evidence_spans": [{"end": 1340, "start": 1211, "text": "y. Treatment with XEC led to an increased rate of pathological complete response in primary tumor (18% vs 6%, respectively, P=0.0"}, {"end": 1408, "start": 1211, "text": "y. Treatment with XEC led to an increased rate of pathological complete response in primary...
TITLE: Effectiveness of an Oral Health Education Program for Obstetrician/Gynecologist Residents at Tufts Medical Center ABSTRACT.AIM AND OBJECTIVES:: To assess Tufts Medical Center obstetrician/gynecologist (OB/GYN) residents' knowledge, beliefs, and previous training in oral health and to assess the effect of a...
Intervention: Oral health educational seminar Comparator: Control Outcome: Score on knowledge-based questions 3 months after intervention
1
{"evidence_spans": [{"end": 1366, "start": 1109, "text": "estions. The post hoc Wilcoxon signed-rank test with Bonferroni correction showed statistically significant improvement in the knowledge-based questions between pre- and post-seminar questionnaire (P = 0.002) and between preseminar and 3-month follow-up (P "}, {...
TITLE: A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy ABSTRACT.OBJECTIVES: To compare the efficacy and safety of SB4 (an etanercept biosimilar) with reference product etanercept (E...
Intervention: SB4 (an etanercept biosimilar) Comparator: etanercept (ETN) Outcome: incidence of antidrug antibody development up to week 24 - Patients with moderate to severe rheumatoid arthritis (RA) despite methotrexate (MTX) treatment
-1
{"evidence_spans": [{"end": 1557, "start": 1445, "text": "2%), and the incidence of antidrug antibody development up to week 24 was lower in SB4 compared with ETN (0.7% v"}, {"end": 19123, "start": 18874, "text": " figure S3).\r\n\r\nBODY.RESULTS.IMMUNOGENICITY:\r\nThe incidence of ADA was significantly lower in SB4 co...
TITLE: The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome ABSTRACT.BACKGROUND/AIMS: Antispasmodics including otilonium bromide (OB) are recommended to treat irritable bowel syndrome (IBS). However, reports about OB experience in Asia is sparse. The purpose of present stu...
Intervention: Otilonium bromide Comparator: Control Outcome: Abdominal pain/discomfort frequency score
0
{"evidence_spans": [{"end": 13570, "start": 13420, "text": "eline IBS symptoms of both arms. There were no differences in terms of age, gender, body mass index, IBS duration, proportions of IBS subtypes, abdomi"}, {"end": 16695, "start": 16225, "text": "hout differences between 2 arms. The net changes of the patient nu...
TITLE: The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome ABSTRACT.BACKGROUND/AIMS: Antispasmodics including otilonium bromide (OB) are recommended to treat irritable bowel syndrome (IBS). However, reports about OB experience in Asia is sparse. The purpose of present stu...
Intervention: Otilonium bromide Comparator: Mebeverine Outcome: Abdominal pain/discomfort frequency score
0
{"evidence_spans": [{"end": 1208, "start": 1012, "text": "nalysis. Compared to baselines in per protocol populations, the reduced APDFSs in OB and mebeverine were 0.55 \u00b1 1.20 (P = 0.011) and 0.37 \u00b1 1.11 (P = 0.042), respectively, to show similarly reduce"}, {"end": 16075, "start": 15891, "text": " changes at ...
TITLE: The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome ABSTRACT.BACKGROUND/AIMS: Antispasmodics including otilonium bromide (OB) are recommended to treat irritable bowel syndrome (IBS). However, reports about OB experience in Asia is sparse. The purpose of present stu...
Intervention: Otilonium bromide Comparator: Mebeverine Outcome: Abdominal bloating
0
{"evidence_spans": [{"end": 1620, "start": 1282, "text": "zziness. Besides, the improved APDFSs at 4th week visit, final alleviations in abdominal pain intensity, flatulence, abdominal bloating and satisfied stool frequency with global assessments filled by both patients and investigators were significantly achieved by...
TITLE: To Evaluate the Efficacy of Topical Propolis in the Management of Symptomatic Oral Lichen Planus: A Randomized Controlled Trial ABSTRACT.INTRODUCTION:: Lichen planus (LP) is a chronic inflammatory, autoimmune, mucocutaneous disease of unknown etiology. The first line of treatment for oral LP (OLP) has been...
Intervention: Triamcinolone acetonide Comparator: No treatment Outcome: Pain
0
{"evidence_spans": [{"end": 1559, "start": 1396, "text": "w-up visit. However, on comparison of the reduction in pain and erythema scores between the two groups, the difference was found to be statistically insignificant "}], "id": "10117", "pmcid": "5863413", "prompt_id": "10117", "split_group_id": "5863413", "votes":...
TITLE: To Evaluate the Efficacy of Topical Propolis in the Management of Symptomatic Oral Lichen Planus: A Randomized Controlled Trial ABSTRACT.INTRODUCTION:: Lichen planus (LP) is a chronic inflammatory, autoimmune, mucocutaneous disease of unknown etiology. The first line of treatment for oral LP (OLP) has been...
Intervention: Triamcinolone acetonide Comparator: No treatment Outcome: Erythema
0
{"evidence_spans": [{"end": 1559, "start": 1396, "text": "w-up visit. However, on comparison of the reduction in pain and erythema scores between the two groups, the difference was found to be statistically insignificant "}], "id": "10120", "pmcid": "5863413", "prompt_id": "10120", "split_group_id": "5863413", "votes":...
TITLE: Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients ABSTRACT: We evaluated the improvement of intact parathyroid hormone (iPTH) levels and bone parameters by supplementing nutritional ...
Intervention: CCC group - oral cholecalciferol (5000 IU/ day) Comparator: CCP group - received a placebo Outcome: Serum (25-hydroxy-vitamin D) 25(OH)D3 levels at 16 weeks - severe secondary hyperparathyroidism (SHPT) hemodialysis (HD) patients
1
{"evidence_spans": [{"end": 13781, "start": 13573, "text": "th week (Table 3 & Figure 2). The median changes in iPTH levels from baseline were significantly different as early as the 16th week of the study, \u2212528.5 \u00b1 148.1 pg/mL in the CCC group vs. \u2212451.6 \u00b1 116.0 pg/m"}, {"end": 15769, "start": 1540...
TITLE: Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients ABSTRACT: We evaluated the improvement of intact parathyroid hormone (iPTH) levels and bone parameters by supplementing nutritional ...
Intervention: CCC group - oral cholecalciferol (5000 IU/ day) Comparator: CCP group - received a placebo Outcome: Serum Intact Parathyroid Hormone (iPTH) average target level (≤300 pg/mL) at 24 weeks - severe secondary hyperparathyroidism (SHPT) hemodialysis (HD) patients
1
{"evidence_spans": [{"end": 13313, "start": 13204, "text": "ELS DURING THE STUDY PERIOD:\r\nAt 24 weeks, an average target iPTH level (\u2264300 pg/mL) was achieved in the CCC "}, {"end": 13572, "start": 13204, "text": "ELS DURING THE STUDY PERIOD:\r\nAt 24 weeks, an average target iPTH level (\u2264300 pg/mL) was achi...
TITLE: Effect of carbonated water manufactured by a soda carbonator on etched or sealed enamel ABSTRACT.OBJECTIVE: The purpose of this study was to determine the effects of carbonated water on etched or sealed enamel according to the carbonation level and the presence of calcium ions. ABSTRACT.METHODS: Carbon...
Intervention: High-level carbonated water with calcium ions Comparator: Control Outcome: Microhardness changes
1
{"evidence_spans": [{"end": 1468, "start": 1294, "text": " 0.000). The microhardness changes in all experimental groups except Group 3 (low-level carbonated water with calcium ions) were significantly greater than those in the Contr"}], "id": "10125", "pmcid": "5702778", "prompt_id": "10125", "split_group_id": "5702778...
TITLE: Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients ABSTRACT: We evaluated the improvement of intact parathyroid hormone (iPTH) levels and bone parameters by supplementing nutritional ...
Intervention: CCC group - oral cholecalciferol (5000 IU/ day) Comparator: CCP group - received a placebo Outcome: Serum (25-hydroxy-vitamin D) 25(OH)D3 levels at end of study - severe secondary hyperparathyroidism (SHPT) hemodialysis (HD) patients
1
{"evidence_spans": [{"end": 15274, "start": 15152, "text": "LEVELS DURING THE STUDY PERIOD:\r\nIn the CCC group, 25(OH)D3 levels increased significantly from 18.2 \u00b1 8.4 to 37.4 \u00b1 9.6 ("}, {"end": 15769, "start": 15152, "text": "LEVELS DURING THE STUDY PERIOD:\r\nIn the CCC group, 25(OH)D3 levels increased sig...
TITLE: Effect of carbonated water manufactured by a soda carbonator on etched or sealed enamel ABSTRACT.OBJECTIVE: The purpose of this study was to determine the effects of carbonated water on etched or sealed enamel according to the carbonation level and the presence of calcium ions. ABSTRACT.METHODS: Carbon...
Intervention: Low-level carbonated water with calcium ions Comparator: Low-level carbonated water Outcome: Microhardness changes
-1
{"evidence_spans": [{"end": 13110, "start": 12916, "text": "ons (Group 3, 32.60 \u00b1 19.83). Low-level carbonated water with calcium ions (Group 3, 32.60 \u00b1 19.83) showed lesser statistically significant change than low-level carbonated water without calcium"}], "id": "10127", "pmcid": "5702778", "prompt_id": "10...
TITLE: Effectiveness of Metacognitive Therapy in Patients with Social Anxiety Disorder: A Pilot Investigation ABSTRACT: Metacognitive therapy (MCT) is a recent psychological intervention for emotional disorders. Its efficacy in social anxiety disorder (SAD) is yet to be established. Aims: We examined the effectiv...
Intervention: Metacognitive therapy (MCT) Comparator: control group received training in applied relaxation (AR) Outcome: social avoidance - in social anxiety disorder (SAD)
-1
{"evidence_spans": [{"end": 860, "start": 801, "text": "d. MCT was more effective than AR in reducing social avoida"}, {"end": 890, "start": 801, "text": "d. MCT was more effective than AR in reducing social avoidance, PEP, and self-consciousne"}], "id": "10640", "pmcid": "5052963", "prompt_id": "10640", "split_group_i...
TITLE: Effectiveness of Metacognitive Therapy in Patients with Social Anxiety Disorder: A Pilot Investigation ABSTRACT: Metacognitive therapy (MCT) is a recent psychological intervention for emotional disorders. Its efficacy in social anxiety disorder (SAD) is yet to be established. Aims: We examined the effectiv...
Intervention: Metacognitive therapy (MCT) Comparator: control group received training in applied relaxation (AR) Outcome: Mean duration of illness - in social anxiety disorder (SAD)
0
{"evidence_spans": [{"end": 1001, "start": 891, "text": "s. While overall both interventions were effective in reducing social anxiety, MCT was marginally more effecti"}, {"end": 8705, "start": 8638, "text": "ange = 26-45 years). Mean duration of illness was 4.92 years (range"}], "id": "10641", "pmcid": "5052963", "pro...
TITLE: Effectiveness of Metacognitive Therapy in Patients with Social Anxiety Disorder: A Pilot Investigation ABSTRACT: Metacognitive therapy (MCT) is a recent psychological intervention for emotional disorders. Its efficacy in social anxiety disorder (SAD) is yet to be established. Aims: We examined the effectiv...
Intervention: Metacognitive therapy (MCT) Comparator: control group received training in applied relaxation (AR) Outcome: Changes on clinical global impression scale-severity (CGI-S) - in social anxiety disorder (SAD)
1
{"evidence_spans": [{"end": 12966, "start": 12808, "text": "n avoidance at follow-up. Changes on CGI-S were higher in patients receiving MCT (60%) as compared to AR (50%), further supporting the effectiveness of MCT i"}, {"end": 12977, "start": 12808, "text": "n avoidance at follow-up. Changes on CGI-S were higher in...
TITLE: Effects of Cooling on Ankle Muscle Strength, Electromyography, and Gait Ground Reaction Forces ABSTRACT: The effects of cooling on neuromuscular function and performance during gait are not fully examined. The purpose of this study was to investigate the effects of local cooling for 20 min in cold water at...
Intervention: Cooling Comparator: Control Outcome: Third peak of coefficient of friction
0
{"evidence_spans": [{"end": 20296, "start": 20130, "text": "Y.3. RESULTS.3.5. THE EFFECTS OF COOLING ON GAIT GROUND REACTION FORCES:\r\nWe found no differences in the GRFs between pre- and postcooling. Neither did the third peak"}, {"end": 20307, "start": 20130, "text": "Y.3. RESULTS.3.5. THE EFFECTS OF COOLING ON GAIT...
TITLE: Comparison of Superficial Mycosis Treatment using Butenafine and Bifonazole nitrate Clinical Efficacy ABSTRACT: Superficial fungal infections are commonly encountered by the physician. And the continuously changing epidemiology of invasive fungal infections results in the need for an expanded armamentarium...
Intervention: Butenafine Comparator: Bifonazole Outcome: Rate of mycologic cure by the end of the treatment
0
{"evidence_spans": [{"end": 1401, "start": 1192, "text": "t. The Rates of mycologic cure and effective treatment with (BTF) were higher than with (BFZ) at cessation of treatment and 2 weeks later. However, no significant difference found between the two drugs (p> 0.0"}], "id": "10134", "pmcid": "4776972", "prompt_id": ...
TITLE: Comparison of Superficial Mycosis Treatment using Butenafine and Bifonazole nitrate Clinical Efficacy ABSTRACT: Superficial fungal infections are commonly encountered by the physician. And the continuously changing epidemiology of invasive fungal infections results in the need for an expanded armamentarium...
Intervention: Butenafine Comparator: Bifonazole Outcome: Rate of effective treatment by the end of the treatment
0
{"evidence_spans": [{"end": 1401, "start": 1192, "text": "t. The Rates of mycologic cure and effective treatment with (BTF) were higher than with (BFZ) at cessation of treatment and 2 weeks later. However, no significant difference found between the two drugs (p> 0.0"}], "id": "10135", "pmcid": "4776972", "prompt_id": ...
TITLE: Comparison of Superficial Mycosis Treatment using Butenafine and Bifonazole nitrate Clinical Efficacy ABSTRACT: Superficial fungal infections are commonly encountered by the physician. And the continuously changing epidemiology of invasive fungal infections results in the need for an expanded armamentarium...
Intervention: Butenafine Comparator: Bifonazole Outcome: Rate of mycologic cure 2 weeks after the treatment
0
{"evidence_spans": [{"end": 1401, "start": 1192, "text": "t. The Rates of mycologic cure and effective treatment with (BTF) were higher than with (BFZ) at cessation of treatment and 2 weeks later. However, no significant difference found between the two drugs (p> 0.0"}], "id": "10136", "pmcid": "4776972", "prompt_id": ...
TITLE: Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial ABSTRACT.SUMMARY.BACKGROUND: Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who rel...
Intervention: mitoxantrone Comparator: idarubicin Outcome: risk of disease-related events (children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens)
-1
{"evidence_spans": [{"end": 17351, "start": 17022, "text": "effect was recorded after allo-SCT. Separation of progression-free survival into disease-related and treatment-related events showed that mitoxantrone reduced the risk of disease-related events (HR 0\u00b756, 95% CI 0\u00b734\u20130\u00b792; Gray's test p=0\u0...
TITLE: Comparison of Superficial Mycosis Treatment using Butenafine and Bifonazole nitrate Clinical Efficacy ABSTRACT: Superficial fungal infections are commonly encountered by the physician. And the continuously changing epidemiology of invasive fungal infections results in the need for an expanded armamentarium...
Intervention: Butenafine Comparator: Bifonazole Outcome: Serious adverse effects
0
{"evidence_spans": [{"end": 9848, "start": 9807, "text": "t difference (p> 0.05) There was not an"}, {"end": 9849, "start": 9807, "text": "t difference (p> 0.05) There was not any"}], "id": "10138", "pmcid": "4776972", "prompt_id": "10138", "split_group_id": "4776972", "votes": {"0": 2}}
TITLE: Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial ABSTRACT.SUMMARY.BACKGROUND: Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who rel...
Intervention: mitoxantrone Comparator: idarubicin Outcome: adjusted hazard ratio (HR) for overall survival (children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens)
1
{"evidence_spans": [{"end": 14698, "start": 14285, "text": "overall survival 57\u00b71% (49\u00b75\u201363\u00b79). Progression-free survival and overall survival were significantly better for mitoxantrone than for idarubicin (figure 3). Mitoxantrone almost halved the hazard of an event at any given timepoint for both ...
TITLE: Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial ABSTRACT.SUMMARY.BACKGROUND: Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who rel...
Intervention: mitoxantrone Comparator: idarubicin Outcome: toxic effects at grade 3 or higher (children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens)
-1
{"evidence_spans": [{"end": 16433, "start": 16177, "text": "e 1\u00b706, 95% CI 0\u00b742\u20132\u00b767, p=0\u00b790). During the whole trial, the number of toxic effects at grade 3 or higher was significantly lower for patients given mitoxantrone than for those given idarubicin (incidence rate ratio mitoxantrone:ida...
TITLE: Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial ABSTRACT.SUMMARY.BACKGROUND: Although survival of children with acute lymphoblastic leukaemia has improved greatly in the past two decades, the outcome of those who rel...
Intervention: mitoxantrone Comparator: idarubicin Outcome: overall survival (children with acute lymphoblastic leukaemia who relapsed on present therapeutic regimens)
1
{"evidence_spans": [{"end": 14394, "start": 14285, "text": "overall survival 57\u00b71% (49\u00b75\u201363\u00b79). Progression-free survival and overall survival were significantly better "}, {"end": 14406, "start": 14285, "text": "overall survival 57\u00b71% (49\u00b75\u201363\u00b79). Progression-free survival and o...
TITLE: Oxidative stress markers in laparoscopic vs. open appendectomy for acute appendicitis: A double-blind randomized study ABSTRACT.BACKGROUND:: Oxidative stress is a complicated process, which was defined as an increase in prooxidants and decrease in antioxidants caused by various mechanisms, including inflam...
Intervention: Laparoscopic appendectomy Comparator: Open appendectomy Outcome: Oxidative stress index
-1
{"evidence_spans": [{"end": 1537, "start": 1339, "text": " 24th h, TOS and OSI were found to be significantly higher in OA group when compared to LA group (P = 0.017 and 0.002) whereas no difference was detected in TAS level in the postoperative 24th h (P "}], "id": "10142", "pmcid": "4810948", "prompt_id": "10142", "s...
TITLE: Randomized trial of distance-based treatment for young children with discipline problems seen in primary health care ABSTRACT.OBJECTIVE.: Many parents of preschool-age children have concerns about how to discipline their child but few receive help. We examined the effects of a brief treatment along with us...
Intervention: Parenting Matters intervention Comparator: Control Outcome: Improvement in psychopathology
1
{"evidence_spans": [{"end": 1441, "start": 1211, "text": "P = 0.033). The Parenting Matters group also demonstrated greater and more rapid improvement than in usual care alone in terms of overall psychopathology (Child Behaviour Checklist, P = 0.02), but there were no group differences i"}], "id": "10149", "pmcid": "35...
TITLE: Effect of eicosapentaenoic acids-rich fish oil supplementation on motor nerve function after eccentric contractions ABSTRACT.BACKGROUND: This study investigated the effect of supplementation with fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the M-wave latency of biceps bra...
Intervention: fish oil group EPA Comparator: control group CON Outcome: maximal voluntary isometric contraction (MVC) torque - after the exercise
1
{"evidence_spans": [{"end": 1947, "start": 1506, "text": "ESULTS:\r\nCompared with the control group, M-wave latency was significantly shorter in the fish oil group immediately after exercise (p = 0.040), MVC torque was significantly higher at 1 day after exercise (p = 0.049), ROM was significantly greater at post and ...
TITLE: Effect of eicosapentaenoic acids-rich fish oil supplementation on motor nerve function after eccentric contractions ABSTRACT.BACKGROUND: This study investigated the effect of supplementation with fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the M-wave latency of biceps bra...
Intervention: fish oil group EPA Comparator: control group CON Outcome: M-wave latency
-1
{"evidence_spans": [{"end": 1640, "start": 1506, "text": "ESULTS:\r\nCompared with the control group, M-wave latency was significantly shorter in the fish oil group immediately after exercise (p"}, {"end": 1641, "start": 1506, "text": "ESULTS:\r\nCompared with the control group, M-wave latency was significantly shorter...
TITLE: Effect of eicosapentaenoic acids-rich fish oil supplementation on motor nerve function after eccentric contractions ABSTRACT.BACKGROUND: This study investigated the effect of supplementation with fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the M-wave latency of biceps bra...
Intervention: fish oil group EPA Comparator: control group CON Outcome: maximal voluntary isometric contraction (MVC) torque - 1 day after the exercise
1
{"evidence_spans": [{"end": 1947, "start": 1506, "text": "ESULTS:\r\nCompared with the control group, M-wave latency was significantly shorter in the fish oil group immediately after exercise (p = 0.040), MVC torque was significantly higher at 1 day after exercise (p = 0.049), ROM was significantly greater at post and ...
TITLE: Retroperitoneal laparoscopic pyelolithotomy in renal pelvic stone versus open surgery - a comparative study ABSTRACT.BACKGROUND: The introduction of endourological procedures such as percutaneous nephrolithotomy and ureterorenoscopy have led to a revolution in the the management of urinary stone disease. T...
Intervention: Retroperitoneal laparoscopic pyelolithotomy Comparator: Open pyelolithotomy Outcome: Hospital stay
-1
{"evidence_spans": [{"end": 1567, "start": 1492, "text": " (p<0.001). The mean hospital stay was less in group A (p<0.03), which was "}], "id": "10159", "pmcid": "5808274", "prompt_id": "10159", "split_group_id": "5808274", "votes": {"-1": 2}}
TITLE: Effect of yoga therapy in reversible inguinal hernia: A quasi experimental study ABSTRACT.BACKGROUND:: Hernia is an abnormal protrusion of an organ or tissue through a defect in its surrounding walls which most commonly involves the abdominal wall, particularly the inguinal region. The treatment options fo...
Intervention: post-Yoga Comparator: pre-Yoga Outcome: frequency of occurrence in reversible inguinal hernia
-1
{"evidence_spans": [{"end": 1061, "start": 907, "text": "SULTS::\r\nThe pre and post interventional data were compared statistically and found significant reduction of symptoms with P\u22640.001 in pain, frequency of o"}, {"end": 13669, "start": 13070, "text": "ervention.\r\n\r\nBODY.MATERIALS AND METHODS.FREQUENCY OF ...
TITLE: The prophylactic role of tranexamic acid to reduce blood loss during radical surgery: A prospective study ABSTRACT.BACKGROUND:: The radical surgical procedures are associated with perioperative blood loss. This study was aimed to evaluate the clinical efficacy and safety of tranexamic acid in reducing peri...
Intervention: Tranexamic acid Comparator: Control Outcome: Complications
0
{"evidence_spans": [{"end": 1507, "start": 1437, "text": "l group. No complications or adverse effects were reported in the eith"}], "id": "10166", "pmcid": "4173437", "prompt_id": "10166", "split_group_id": "4173437", "votes": {"0": 1}}
TITLE: The prophylactic role of tranexamic acid to reduce blood loss during radical surgery: A prospective study ABSTRACT.BACKGROUND:: The radical surgical procedures are associated with perioperative blood loss. This study was aimed to evaluate the clinical efficacy and safety of tranexamic acid in reducing peri...
Intervention: Tranexamic acid Comparator: Control Outcome: Adverse effects
0
{"evidence_spans": [{"end": 1507, "start": 1437, "text": "l group. No complications or adverse effects were reported in the eith"}], "id": "10167", "pmcid": "4173437", "prompt_id": "10167", "split_group_id": "4173437", "votes": {"0": 2}}
TITLE: Estimation of inhalation flow profile using audio-based methods to assess inhaler medication adherence ABSTRACT: Asthma and chronic obstructive pulmonary disease (COPD) patients are required to inhale forcefully and deeply to receive medication when using a dry powder inhaler (DPI). There is a clinical nee...
Intervention: High flow Comparator: Low flow Outcome: a and b model coefficients (power law models)
1
{"evidence_spans": [{"end": 22186, "start": 21934, "text": "e audio envelope and the flow signal. It was observed that the a and b model coefficients at the High flow range were statistically significantly higher than those in the Medium (p<0.05 for a coefficient, p<0.01 for b coefficient) and Low (p<0.01 for "}], "id...
TITLE: Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops ABSTRACT.PURPOSE: This study aimed to compare the efficacy of two sustained-release formulation of artificial tear drops. ABSTRACT.PATIENTS AND METHODS: This is a randomized ...
Intervention: Artificial tear single dose Comparator: Artificial tear multiple dose Outcome: Conjunctival score
0
{"evidence_spans": [{"end": 1707, "start": 1160, "text": "ctively. In comparing two groups before the intervention, the OSDI scores, the TBUT scores, the conjunctival and corneal staining scores and the Schirmer scores did not show statistically significant differences (p = 0.339, p = 0.640, p = 0.334, p = 0.807 and p ...
TITLE: Uterine salvage management for atonic postpartum hemorrhage using “modified lynch suture” ABSTRACT.BACKGROUND: To assess the effectiveness of the new modified technique in order to control bleeding in women presenting with atonic, flabby uterus compared to the most commonly described technique of classic B...
Intervention: Modified lynch suture Comparator: Classic technique Outcome: Need for blood transfusion
-1
{"evidence_spans": [{"end": 8604, "start": 8553, "text": "rative blood loss324 \u00b1 105568 \u00b1 2090.0001 (HS)Need "}, {"end": 8607, "start": 8553, "text": "rative blood loss324 \u00b1 105568 \u00b1 2090.0001 (HS)Need for"}], "id": "10182", "pmcid": "5002172", "prompt_id": "10182", "split_group_id": "5002172", "vot...
TITLE: Uterine salvage management for atonic postpartum hemorrhage using “modified lynch suture” ABSTRACT.BACKGROUND: To assess the effectiveness of the new modified technique in order to control bleeding in women presenting with atonic, flabby uterus compared to the most commonly described technique of classic B...
Intervention: Modified lynch suture Comparator: Classic technique Outcome: Postoperative blood loss
-1
{"evidence_spans": [{"end": 8549, "start": 8500, "text": "al birth weight3.496 \u00b1 0.3653.397 \u00b1 0.3890.099Pos"}], "id": "10183", "pmcid": "5002172", "prompt_id": "10183", "split_group_id": "5002172", "votes": {"-1": 2}}
TITLE: Uterine salvage management for atonic postpartum hemorrhage using “modified lynch suture” ABSTRACT.BACKGROUND: To assess the effectiveness of the new modified technique in order to control bleeding in women presenting with atonic, flabby uterus compared to the most commonly described technique of classic B...
Intervention: Modified lynch suture Comparator: Classic technique Outcome: Post-operative hemoglobin
0
{"evidence_spans": [{"end": 8808, "start": 8767, "text": " (HS)Pre-operative Hb%9.8 \u00b1 1.210.1 \u00b1 1.3"}], "id": "10184", "pmcid": "5002172", "prompt_id": "10184", "split_group_id": "5002172", "votes": {"0": 2}}
TITLE: Effects of Adding Sodium Nitroprusside to Semen Diluents on Motility, Viability and Lipid Peroxidation of Sperm in Holstein Bulls ABSTRACT.BACKGROUND: Nitric oxide (NO) that plays important role in all sexual activities of animals is made from the amino acid L-arginine by the enzymatic action of NO synt...
Intervention: Sodium nitroprusside 10 nmol/ml Comparator: Control Outcome: Spermatozoa viability
1
{"evidence_spans": [{"end": 1730, "start": 1526, "text": "\n\r\nABSTRACT.RESULTS:\r\nAll concentrations of SNP used was found to increase motility and viability of spermatozoa at 1, 2 and 3 hours after thawing, significantly (P<0.05), but there was no significant\r\ndi"}, {"end": 10391, "start": 10244, "text": ".36 b T...
TITLE: Effects of Adding Sodium Nitroprusside to Semen Diluents on Motility, Viability and Lipid Peroxidation of Sperm in Holstein Bulls ABSTRACT.BACKGROUND: Nitric oxide (NO) that plays important role in all sexual activities of animals is made from the amino acid L-arginine by the enzymatic action of NO synt...
Intervention: Sodium nitroprusside 50 nmol/ml Comparator: Control Outcome: Spermatozoa viability
1
{"evidence_spans": [{"end": 1730, "start": 1526, "text": "\n\r\nABSTRACT.RESULTS:\r\nAll concentrations of SNP used was found to increase motility and viability of spermatozoa at 1, 2 and 3 hours after thawing, significantly (P<0.05), but there was no significant\r\ndi"}, {"end": 10391, "start": 10244, "text": ".36 b T...
TITLE: Evaluation of the ability of continuous palonosetron infusion, using a patient-controlled analgesia device, to reduce postoperative nausea and vomiting ABSTRACT.BACKGROUND: The efficacy of palonosetron in preventing postoperative nausea and vomiting (PONV), as well as chemotherapy-induced nausea and vomiti...
Intervention: Continuous palonosetron infusion Comparator: Single-injection palonosetron Outcome: Vomiting
-1
{"evidence_spans": [{"end": 1342, "start": 1152, "text": "ESULTS:\r\nThe incidence of PONV 24 hours postoperatively was significantly lower in the continuous palonosetron infusion group than the single-injection palonosetron group (31.8 vs. 56.1%, P "}], "id": "10197", "pmcid": "4166382", "prompt_id": "10197", "split_g...
TITLE: Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema ABSTRACT.PURPOSE: To compare the short-term effects of intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. ABSTRACT.METHODS: This is a prospective a...
Intervention: Intravitreal triamcinolone Acetonide Comparator: Posterior subtenon triamcinolone Acetonide Outcome: Visual acuity after 1 month
0
{"evidence_spans": [{"end": 7585, "start": 7009, "text": "hroughout the study. In the intravitreal injection group, the mean visual acuity at 1 month (0.571\u00b10.393; p=0.001) and 3 months (0.535\u00b10.382; p=0.001) after the injection were significantly better than baseline measurements. In the posterior subtenon i...
TITLE: Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema ABSTRACT.PURPOSE: To compare the short-term effects of intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. ABSTRACT.METHODS: This is a prospective a...
Intervention: Intravitreal triamcinolone Acetonide Comparator: Posterior subtenon triamcinolone Acetonide Outcome: Visual acuity after 3 months
0
{"evidence_spans": [{"end": 7585, "start": 6930, "text": " 2 groups (p=0.338). In both groups, the visual acuity significantly improved throughout the study. In the intravitreal injection group, the mean visual acuity at 1 month (0.571\u00b10.393; p=0.001) and 3 months (0.535\u00b10.382; p=0.001) after the injection we...
TITLE: Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema ABSTRACT.PURPOSE: To compare the short-term effects of intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. ABSTRACT.METHODS: This is a prospective a...
Intervention: Intravitreal triamcinolone Acetonide Comparator: Posterior subtenon triamcinolone Acetonide Outcome: Central macular thickness after 1 month
0
{"evidence_spans": [{"end": 8078, "start": 7673, "text": " 2 groups (p=0.461). In both the intravitreal and posterior subtenon injection group, the CMT was significantly decreased through the study (Table 3, Fig. 2). At 3 months after injection, OCT demonstrated a reduction of the mean CMT (intravitreal group: 46.2%, s...
TITLE: The comparative effectiveness of Integrated treatment for Substance abuse and Partner violence (I-StoP) and substance abuse treatment alone: a randomized controlled trial ABSTRACT.BACKGROUND: Research has shown that treatments that solely addressed intimate partner violence (IPV) perpetration were not very...
Intervention: Integrated treatment for Substance abuse and Partner violence Comparator: Cognitive-Behavioral Therapy for Substance Use Disorders Outcome: Days of abstinence
0
{"evidence_spans": [{"end": 34235, "start": 34112, "text": ": Z (10) = \u22122.05; p = .02 (1-tailed); CBT-SUD+: Z (7) = \u22122.37; p = .01 (1-tailed)). There were no statistically significant"}, {"end": 34293, "start": 34113, "text": " Z (10) = \u22122.05; p = .02 (1-tailed); CBT-SUD+: Z (7) = \u22122.37; p = .01 (1-...
TITLE: Using Attentional Bias Modification as a Cognitive Vaccine Against Depression ABSTRACT.BACKGROUND: Negative attentional biases are thought to increase the risk of recurrence in depression, suggesting that reduction of such biases may be a plausible strategy in the secondary prevention of the illness. Howev...
Intervention: Word-based attentional bias modification Comparator: Placebo Outcome: Difference of cortisol on waking and the highest level of following samples
0
{"evidence_spans": [{"end": 1536, "start": 1265, "text": "ESULTS:\r\nPositive, face-based ABM reduced both measures of recurrence risk (Beck Depression Inventory and cortisol awakening response). This effect occurred during the month following completion of bias modification. Word-based modification did not influence t...
TITLE: Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes ABSTRACT.OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations...
Intervention: Insulin aspart Comparator: Insulin lispro Outcome: Fasting plasma C-Peptide
0
{"evidence_spans": [{"end": 1286, "start": 1085, "text": "SULTS:\r\n There were no significant differences in daily dosages of insulin, fasting plasma C-P and 2 h postprandial C-P and insulin, and fructosamine at the baseline and endpoint between the groups Asp"}], "id": "10227", "pmcid": "5892275", "prompt_id": "10227...
TITLE: Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes ABSTRACT.OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations...
Intervention: Insulin aspart Comparator: Insulin lispro Outcome: 2 h postprandial C-Peptide
0
{"evidence_spans": [{"end": 1286, "start": 1085, "text": "SULTS:\r\n There were no significant differences in daily dosages of insulin, fasting plasma C-P and 2 h postprandial C-P and insulin, and fructosamine at the baseline and endpoint between the groups Asp"}], "id": "10228", "pmcid": "5892275", "prompt_id": "10228...
TITLE: Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes ABSTRACT.OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations...
Intervention: Insulin aspart Comparator: Insulin lispro Outcome: Fructosamine
0
{"evidence_spans": [{"end": 1286, "start": 1085, "text": "SULTS:\r\n There were no significant differences in daily dosages of insulin, fasting plasma C-P and 2 h postprandial C-P and insulin, and fructosamine at the baseline and endpoint between the groups Asp"}, {"end": 13941, "start": 13817, "text": "is from baselin...
TITLE: Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes ABSTRACT.OBJECTIVE: To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations...
Intervention: Insulin aspart Comparator: Insulin lispro Outcome: Mean amplitude of glycemic excursions
0
{"evidence_spans": [{"end": 1570, "start": 1287, "text": "and Lis. No significant differences were seen in the 24 h mean amplitude of glycemic excursions (MAGE), 24 h mean blood glucose (MBG), the standard deviation of the MBG (SDBG), fasting blood glucose, number of glycemic excursion (NGE), and the incidence of hypog...
TITLE: The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial ABSTRACT.CONTEXT:: Resveratrol has been used for the treatment of endometriosis. ABSTRACT.OBJECTIVE:: To compare resveratrol (40 mg/d) with monophasic contraceptive pill (COC) to COC with placebo for t...
Intervention: Resveratrol Comparator: Placebo Outcome: Need for dipyrone
0
{"evidence_spans": [{"end": 16181, "start": 16102, "text": "ebo (n = 22) P Value Subjects that used pain medication (n) 7 8 \u2003Dipyrone, mg:"}], "id": "10233", "pmcid": "5686687", "prompt_id": "10233", "split_group_id": "5686687", "votes": {"0": 1}}
TITLE: The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial ABSTRACT.CONTEXT:: Resveratrol has been used for the treatment of endometriosis. ABSTRACT.OBJECTIVE:: To compare resveratrol (40 mg/d) with monophasic contraceptive pill (COC) to COC with placebo for t...
Intervention: Resveratrol Comparator: Placebo Outcome: Prolactin levels
0
{"evidence_spans": [{"end": 16996, "start": 16926, "text": "A-125 (U/mL) at day 42 a 11.7 (4.9 to 29.9) 13.7 (5 to 61) 0.1 b \u2003Prol"}, {"end": 18030, "start": 17948, "text": "M-2 Way ANOVA) and the resveratrol group (P = 0.02; RM-2 Way ANOVA). Prolactin lev"}], "id": "10235", "pmcid": "5686687", "prompt_id": "10235...
TITLE: The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial ABSTRACT.CONTEXT:: Resveratrol has been used for the treatment of endometriosis. ABSTRACT.OBJECTIVE:: To compare resveratrol (40 mg/d) with monophasic contraceptive pill (COC) to COC with placebo for t...
Intervention: Resveratrol Comparator: Placebo Outcome: CA-125 levels
0
{"evidence_spans": [{"end": 18030, "start": 17802, "text": "\r\n\r\nBODY.2. RESULTS.C. SECONDARY OUTCOME.C-1. CA-125 AND PROLACTIN:\r\nCA-125 levels were reduced after 42 days of treatment in placebo (P = 0.01; RM-2 Way ANOVA) and the resveratrol group (P = 0.02; RM-2 Way ANOVA). Prolactin lev"}], "id": "10236", "pmcid...
TITLE: Effect-Site Concentration of Remifentanil for Minimizing Cardiovascular Changes by Inhalation of Desflurane ABSTRACT.PURPOSE: This study aims to investigate the most appropriate effect-site concentration of remifentanil to minimize cardiovascular changes during inhalation of high concentration desflurane. ...
Intervention: Remifentanil 6 ng/mL Comparator: Remifentanil 4 ng/mL Outcome: Systolic blood pressure
-1
{"evidence_spans": [{"end": 11500, "start": 11394, "text": "fter 2 minutes of inhalation. The SBP of group R6 was significantly lower 3 minutes after inhalation compa"}], "id": "8141", "pmcid": "3635645", "prompt_id": "8141", "split_group_id": "3635645", "votes": {"-1": 2}}
TITLE: Can Targeted Intervention Mitigate Early Emotional and Behavioral Problems?: Generating Robust Evidence within Randomized Controlled Trials ABSTRACT: This study examined the impact of a targeted Irish early intervention program on children's emotional and behavioral development using multiple methods to te...
Intervention: intervention group, involving home visits Comparator: control group Outcome: Total problems
0
{"evidence_spans": [{"end": 1441, "start": 1323, "text": "e. No effects were observed for girls or for the continuous measures of Total, Internalizing, and Externalizing proble"}, {"end": 38171, "start": 37893, "text": "gram's impact for the original sample. All three coefficients on treatment status were negative, imp...
TITLE: Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes ( ABSTRACT.AIMS: To compare the once‐weekly glucagon‐like peptide‐1 (GLP‐1) receptor dulaglutide with the dipeptidyl peptidase‐4 (DPP‐4) inhibitor sitagliptin after 104 weeks o...
Intervention: dulaglutide (1.5 or 0.75 mg) Comparator: sitagliptin 100 mg Outcome: Gastrointestinal adverse events
1
{"evidence_spans": [{"end": 1579, "start": 1386, "text": "tively). Gastrointestinal adverse events were more common with dulaglutide 1.5 and 0.75 mg versus sitagliptin (nausea 17 and 15% vs 7%, diarrhoea 16 and 12% vs 6%, vomiting 14 and 8% vs 4% resp"}, {"end": 1580, "start": 1386, "text": "tively). Gastrointestinal a...
TITLE: Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes ( ABSTRACT.AIMS: To compare the once‐weekly glucagon‐like peptide‐1 (GLP‐1) receptor dulaglutide with the dipeptidyl peptidase‐4 (DPP‐4) inhibitor sitagliptin after 104 weeks o...
Intervention: dulaglutide (1.5 or 0.75 mg) Comparator: sitagliptin 100 mg Outcome: mean HbA1c changes
1
{"evidence_spans": [{"end": 14511, "start": 14228, "text": ", respectively (Figure 2A). The LS mean HbA1c changes were superior with dulaglutide 1.5 mg [LS mean difference (95% confidence interval) \u22120.67% (\u22120.84, \u22120.50) or \u22127.32 mmol/mol (\u22129.18, \u22125.47)] and dulaglutide 0.75 mg [\u22120.39%...
TITLE: Effect-Site Concentration of Remifentanil for Minimizing Cardiovascular Changes by Inhalation of Desflurane ABSTRACT.PURPOSE: This study aims to investigate the most appropriate effect-site concentration of remifentanil to minimize cardiovascular changes during inhalation of high concentration desflurane. ...
Intervention: Remifentanil 6 ng/mL Comparator: Remifentanil 2 ng/mL Outcome: Diastolic blood pressure
-1
{"evidence_spans": [{"end": 11934, "start": 11780, "text": "r inhalation in group R6 (p<0.05). Comparing the DBP among the three groups, DBP of group R2 was significantly higher 1 and 2 minutes after inhalation tha"}, {"end": 11934, "start": 11782, "text": "inhalation in group R6 (p<0.05). Comparing the DBP among the t...
TITLE: Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes ( ABSTRACT.AIMS: To compare the once‐weekly glucagon‐like peptide‐1 (GLP‐1) receptor dulaglutide with the dipeptidyl peptidase‐4 (DPP‐4) inhibitor sitagliptin after 104 weeks o...
Intervention: dulaglutide (1.5 or 0.75 mg) Comparator: sitagliptin 100 mg Outcome: At 104 weeks, the percentage of participants attaining the HbA1c target goal of <7%
1
{"evidence_spans": [{"end": 16045, "start": 15776, "text": "iptin.DOM-12479-FIG-0002-c At 104 weeks, the percentage of participants attaining the HbA1c target goal of <7.0% (<53.0 mmol/mol) was significantly higher in the dulaglutide 1.5 mg and dulaglutide 0.75 mg arms (54 and 45%, respectively) compared with sitaglip...
TITLE: Effect-Site Concentration of Remifentanil for Minimizing Cardiovascular Changes by Inhalation of Desflurane ABSTRACT.PURPOSE: This study aims to investigate the most appropriate effect-site concentration of remifentanil to minimize cardiovascular changes during inhalation of high concentration desflurane. ...
Intervention: Remifentanil 4 ng/mL Comparator: Remifentanil 2 ng/mL Outcome: Diastolic blood pressure
-1
{"evidence_spans": [{"end": 11934, "start": 11782, "text": "inhalation in group R6 (p<0.05). Comparing the DBP among the three groups, DBP of group R2 was significantly higher 1 and 2 minutes after inhalation tha"}], "id": "8144", "pmcid": "3635645", "prompt_id": "8144", "split_group_id": "3635645", "votes": {"-1": 2}}
TITLE: Can Targeted Intervention Mitigate Early Emotional and Behavioral Problems?: Generating Robust Evidence within Randomized Controlled Trials ABSTRACT: This study examined the impact of a targeted Irish early intervention program on children's emotional and behavioral development using multiple methods to te...
Intervention: intervention group, involving home visits Comparator: control group Outcome: rate of attrition
0
{"evidence_spans": [{"end": 37128, "start": 37045, "text": "edge of infant development. While the rate of attrition was equal for both groups"}, {"end": 37128, "start": 37049, "text": " of infant development. While the rate of attrition was equal for both groups"}], "id": "8101", "pmcid": "4890862", "prompt_id": "8...
TITLE: Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders ABSTRACT.BACKGROUND: Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel ...
Intervention: lubiprostone (24 mcg BID for CIC) Comparator: placebo for each indication Outcome: chronic idiopathic constipation (CIC) - incidence of treatment-emergent nausea
1
{"evidence_spans": [{"end": 15631, "start": 15331, "text": "th CIC or IBS-C (Table 2).\r\n\r\nBODY.RESULTS.NAUSEA INCIDENCES DURING TREATMENT:\r\nThe crude incidence of treatment-emergent nausea in the RCT populations was significantly higher in patients who received lubiprostone (24 mcg BID for CIC and OIC; 8 mcg BID ...
TITLE: Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders ABSTRACT.BACKGROUND: Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel ...
Intervention: lubiprostone (24 mcg BID for OIC) Comparator: placebo for each indication Outcome: opioid-induced constipation (OIC) - incidence of treatment-emergent nausea, mild or moderate
1
{"evidence_spans": [{"end": 16244, "start": 16014, "text": "than placebo (19.2 vs 3.3%, 7.9 vs 2.9%, and 2.1 vs 0%, respectively; Table 2). For the OIC analysis, the percentages of patients in RCTs reporting mild (8.0 vs 3.7%) and moderate (4.4 vs 1.7%), but not severe (1.1 vs 1.1%) nausea"}], "id": "8046", "pmcid": "5...
TITLE: Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment ABSTRACT: Although direct‐acting antiviral (DAA) therapies for chronic hepatitis C virus (HCV) infection have demonstrated high rates of sustained virologic response, virologic f...
Intervention: Glecaprevir 300mg + pibrentasvir 120 mg + ribavirin Comparator: Glecaprevir 300mg + pibrentasvir 120 mg Outcome: Discontinuation due to adverse events
0
{"evidence_spans": [{"end": 21308, "start": 21240, "text": "mur and breast cancer). No patient prematurely discontinued treatmen"}, {"end": 21851, "start": 21818, "text": "16.7) a \r\n 1 (4.5) b \r\n 0 Discont"}], "id": "8150", "pmcid": "5573922", "prompt_id": "8150", "split_group_id": "5573922", "votes": {"0": 2}}
TITLE: Physical therapy for airway clearance improves cardiac autonomic modulation in children with acute bronchiolitis ABSTRACT.BACKGROUND: The effects of physical therapy on heart rate variability (HRV), especially in children, are still inconclusive. ABSTRACT.OBJECTIVE: We investigated the effects of co...
Intervention: acute bronchiolitis group (BG); conventional physical therapy (CPT) for airway clearance and nasotracheal suction Comparator: control group (CG); conventional physical therapy (CPT) for airway clearance Outcome: higher LF/HF ratio in HRV
1
{"evidence_spans": [{"end": 11548, "start": 11400, "text": "e characterized by major\r\noscillations in the LF band and minor oscillations in the HF band in absolute and\r\nnormalized units when compared to the C"}], "id": "8000", "pmcid": "4207147", "prompt_id": "8000", "split_group_id": "4207147", "votes": {"1": 1}}
TITLE: The effect of triazolam premedication on anxiety, sedation, and amnesia in general anesthesia ABSTRACT.BACKGROUND: Benzodiazepines have been used preoperatively as part of an anesthesia regimen to attenuate the anxiety of patients. In this study, we aimed to examine the effect of oral triazolam, a short-ac...
Intervention: triazolam 0.25 mg or 0.375 mg Comparator: no premedication Outcome: anxiety scores
0
{"evidence_spans": [{"end": 1100, "start": 989, "text": "ESULTS:\r\nChanges in the anxiety and sedation scores on the day of surgery were not significantly different amon"}, {"end": 10216, "start": 10105, "text": "ificant (P = 0.167). The changes in anxiety scores from baseline were also not statistically different amo...
TITLE: New strategies to manage complicated pleural effusions ABSTRACT.EXPANDED ABSTRACT.CITATION: Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, Bentley A, Kahan BC, Wrightson JM, Davies HE, Hooper CE, Lee YC, Hedley EL, Crosthwaite N, Choo L, Helm EJ, Glees...
Intervention: Tissue plasminogen activator Comparator: Placebo Outcome: Pleural opacity
0
{"evidence_spans": [{"end": 2197, "start": 2029, "text": "P = 0.005). The change observed with t-PA alone and with DNase alone (-17.2 \u00b1 24.3 and -14.7 \u00b1 16.4%, respectively) was not significantly different from that observed w"}], "id": "8152", "pmcid": "3580622", "prompt_id": "8152", "split_group_id": "35806...